New Genetic Abnormalities and Treatment Response in Acute Lymphoblastic Leukemia

被引:32
作者
Meijerink, Jules P. P. [1 ]
den Boer, Monique L. [1 ]
Pieters, Rob [1 ]
机构
[1] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Pediat Oncol Hematol, NL-3015 GJ Rotterdam, Netherlands
关键词
VITRO DRUG-RESISTANCE; PEDIATRIC T-ALL; TUMOR-SUPPRESSOR; FLT3; MUTATIONS; CHROMOSOMAL TRANSLOCATIONS; PROGNOSTIC-SIGNIFICANCE; EXPRESSION SIGNATURES; HOX11L2; EXPRESSION; CHILDHOOD; FUSION;
D O I
10.1053/j.seminhematol.2008.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Numerous genetic abnormalities have been identified in acute lymphoblastic leukemia (ALL). Here we review the recurrent abnormalities with emphasis on those recently discovered, and discuss their association with chemotherapy resistance or sensitivity and with clinical response to therapy. Also, the role of genetic abnormalities in leukemogenesis and their potential as therapeutic targets will be discussed. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 70 条
[1]   FLT3 mutations in a 10 year consecutive series of 177 childhood acute Leukemias and their impact on global gene expression patterns [J].
Andersson, Anna ;
Paulsson, Kajsa ;
Lilljebjorn, Henrik ;
Lassen, Carin ;
Strombeck, Bodil ;
Heldrup, Jesper ;
Behrendtz, Mikael ;
Johansson, Bertil ;
Fioretos, Thoas .
GENES CHROMOSOMES & CANCER, 2008, 47 (01) :64-70
[2]   Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification [J].
Armstrong, SA ;
Kung, AL ;
Mabon, ME ;
Silverman, LB ;
Stam, RW ;
Den Boer, ML ;
Pieters, R ;
Kersey, JH ;
Sallan, SE ;
Fletcher, JA ;
Golub, TR ;
Griffin, JD ;
Korsmeyer, SJ .
CANCER CELL, 2003, 3 (02) :173-183
[3]   FLT3 mutations in childhood acute lymphoblastic leukemia [J].
Armstrong, SA ;
Mabon, ME ;
Silverman, LB ;
Li, AH ;
Gribben, JG ;
Fox, EA ;
Sallan, SE ;
Korsmeyer, SJ .
BLOOD, 2004, 103 (09) :3544-3546
[4]   CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR-γδ lineage [J].
Asnafi, V ;
Radford-Weiss, I ;
Dastugue, N ;
Bayle, C ;
Leboeuf, D ;
Charrin, C ;
Garand, R ;
Lafage-Pochitaloff, M ;
Delabesse, E ;
Buzyn, A ;
Troussard, X ;
Macintyre, E .
BLOOD, 2003, 102 (03) :1000-1006
[5]   Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression:: experience of the German multicenter ALL study group [J].
Baak, U. ;
Goekbuget, N. ;
Orawa, H. ;
Schwartz, S. ;
Hoelzer, D. ;
Thiel, E. ;
Burmeister, T. .
LEUKEMIA, 2008, 22 (06) :1154-1160
[6]   Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis [J].
Balgobind, Brian V. ;
Van Vlierberghe, Pieter ;
van den Ouweland, Ans M. W. ;
Beverloo, H. Berna ;
Terlouw-Kromosoeto, Joan N. R. ;
van Wering, Elisabeth R. ;
Reinhardt, Dirk ;
Horstmann, Martin ;
Kaspers, Gertjan J. L. ;
Pieters, Rob ;
Zwaan, C. Michel ;
Van den Heuvel-Eibrink, Marry M. ;
Meijerink, Jules P. P. .
BLOOD, 2008, 111 (08) :4322-4328
[7]  
Batova A, 1997, CANCER RES, V57, P832
[8]   Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia [J].
Breit, Stephen ;
Stanulla, Martin ;
Flohr, Thomas ;
Schrappe, Martin ;
Ludwig, Wolf-Dieter ;
Tolle, Gabriele ;
Happich, Margit ;
Muckenthaler, Martina U. ;
Kulozik, Andreas E. .
BLOOD, 2006, 108 (04) :1151-1157
[9]   FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression [J].
Brown, P ;
Levis, M ;
Shurtleff, S ;
Campana, D ;
Downing, J ;
Small, D .
BLOOD, 2005, 105 (02) :812-820
[10]   Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia [J].
Case, Marian ;
Matheson, Elizabeth ;
Minto, Lynne ;
Hassan, Rosline ;
Harrison, Christine J. ;
Bown, Nick ;
Bailey, Simon ;
Vormoor, Josef ;
Hall, Andrew G. ;
Irving, Julie A. E. .
CANCER RESEARCH, 2008, 68 (16) :6803-6809